Christina Zhang is partner and chief representative of Cooley's Shanghai office. Christina has more than 20 years of practice experience, gained through private practice and in–house experience in the US and China. Christina represents clients and investment funds in cross border transactions, especially in life sciences and high tech industries. She has represented clients in their financings, licensing and partnership transactions, joint ventures, acquisitions and divestitures, manufacturing, distribution and marketing activities in China and US. 

Download full bio 


  • Johnson Controls Joint Venture Named a Deal of the Year by China Business Law Journal 

  • FibroGen Closes Largest Biotech IPO in 12 Years 

  • Uber Closes SoftBank Investment 

  • Johnson Controls on $7.5 Billion Joint Venture with SAIC's Yanfeng Automotive Trim Systems 

  • GENFIT SA in its Licensing and Collaboration Agreement with Terns Pharmaceuticals 

  • View all


  • Duke University School of Law
    JD, 1993

  • University of International Business and Economics
    BA, Economics

Admissions & Credentials

New York

Rankings & Accolades

    The Legal 500 Asia Pacific
    Life Sciences and Healthcare in China: Leading Individuals

    Chambers and Partners Greater China
    Life Sciences in China: Ranked Lawyer

    China Business Law Journal: China A-List Lawyers
    (2019 - 2022)